Literature DB >> 32354693

COVID-19, head and neck cancer, and the need of training of health students and practitioners regarding to tobacco control and patient counseling.

Augusto César Leal da Silva Leonel1, Hercílio Martelli-Junior2, Paulo Rogério Ferreti Bonan3, Luiz Paulo Kowalski4, Danyel Elias da Cruz Perez5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32354693      PMCID: PMC7180372          DOI: 10.1016/j.oraloncology.2020.104739

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


× No keyword cloud information.
On March 11, 2020, the World Health Organization (WHO) decreed the COVID-19 pandemic, a disease caused by a novel RNA betacoronavirus (SARS-CoV-2). The COVID-19 pathogenesis is complex. In summary, the virus infects and replicates mainly in the epithelial cells of the respiratory mucosa. This peculiarity can lead to severe acute respiratory syndrome and death [1]. By the April 21th, 2020, there were more than 2.5 million of cases confirmed, with 177,000 deaths (https://coronavirus.jhu.edu/map.html). Tobacco is an important risk factor for a number of diseases, such as cardiovascular disease, cancer, and chronic obstructive pulmonary disease. Recently, it has also been identified as a risk factor for complications associated with COVID-19. Exposure to tobacco smoke causes bronchopulmonary inflammation, increased permeability of respiratory epithelial cells, overproduction of mucus and impaired mucociliary clearance [1]. Tobacco consumption increases the expression of angiotensin-converting enzyme 2, which is a binding receptor for SARS-CoV2 virus [2]. A meta-analysis including 8 studies and 46,248 COVID-19 patients showed that cardiovascular and chronic respiratory diseases (highly associated to tobacco smoking) were the most prevalent comorbidities among the patients that had severe acute respiratory syndrome [3]. Analyzing the projection of the transmission dynamics of COVID-19, in the absence of an effective preventive measure, possibly there will be a need for intermittent or prolonged isolation and social distancing measures until 2022. Even in periods of apparent control of the pandemic, surveillance must be maintained, as the risk of a resurgence of new COVID-19 waves may be possible until 2024 [4]. The emergence of new respiratory diseases in the future, such as COVID-19, should also be considered at this time. Knowledge about host factors, especially preventable factors such as active and passive smoking, may be important in reducing the severity of the disease and, consequently, decreasing the number of deaths [1]. Tobacco-free policies must be maintained and strengthened. Moreover, the training of health students in relation to the perception, counseling and guidance of smoking patients can be crucial. Health professionals should be also able to discourage the emergence of new smokers [5]. Most head and neck cancers (HNC) are tobacco-induced. Particularly for oral cavity, although the current trends in oral squamous cell carcinoma (OSCC) indicate an increasing prevalence in young and non‐smoker patients, most OSCC still occur in older smokers [6]. In former smokers, the risk for HNC have decreased after 1–4 years (OR 0.70) after smoking cessation. After 20 years of quitting smoking, the risk of oral and pharyngeal cancer was similar to that of never smokers [7]. At any time, smoking cessation is crucial. A large population-based study reveals that smoking at diagnosis was an independent prognostic factor for cancer-specific survival in HNC [8]. Considering the current global health crisis, concern about the COVID-19 pandemic may encourage smoking cessation, resulting in a greater number of patients who need counseling and guidance to quitting smoking. In this likely scenario, is health professional and students training, particularly dental and medical students, suitable to patients counseling for smoking cessation? In 2005, The WHO, The Centers for Disease Control and Prevention in USA, and Canadian Public Health Association, developed and implemented the Global Health Professions Students Survey (GHPSS). Several countries have already applied this survey, pointing out that more than 80% of health students find that health professionals have a role in counseling patients about smoking cessation. However, less than 40% of students reported having received any formal training on tobacco cessation approaches and smoking counseling during their professional education [9]. Recently, we evidenced that 95.5% of dental students mentioned having knowledge about the harmful effects of tobacco during their training. However, only 22.5% received some training in counseling patients to quit smoking and approximately 50% never heard about smoking cessation programs [10]. In addition, training and continuing education of health professionals are essential. A systematic review and meta-analysis suggested that professionals who received training were more likely to assess smoking status, counseling their patients to quit smoking, when compared to untrained controls [5]. In summary, tobacco is a causative and/or modifying factor for the aggravation of several diseases, particularly the COVID-19. Moreover, after COVID-19 pandemic, the number of patients motivated to smoking cessation may increase, requiring suitable training of health practitioners. In addition, impact on survival and trends of tobacco-induced cancers may be expected, particularly HNC. Therefore, Universities and Health Professional Associations, especially Medical and Dental, should invest heavily in the training of health students in relation the perception, and smokers counseling. In this sense, efforts for continuing education actions are also essential for health practitioners.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  8 in total

Review 1.  Training health professionals in smoking cessation.

Authors:  Kristin V Carson; Marjolein E A Verbiest; Mathilde R Crone; Malcolm P Brinn; Adrian J Esterman; Willem J J Assendelft; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Tobacco Use, Attitudes, Knowledge, and Perception About Smoking Cessation Counseling Among Brazilian Dental Students: a Cross-Sectional Study.

Authors:  Augusto César Leal da Silva Leonel; Paulo Rogério Ferreti Bonan; Jurema Freire Lisboa de Castro; Andréa Dos Anjos Pontual; Flávia Maria de Moraes Ramos-Perez; Daniela Silva Feitosa; Danyel Elias da Cruz Perez
Journal:  J Cancer Educ       Date:  2021-02       Impact factor: 2.037

3.  Smoking at diagnosis is an independent prognostic factor for cancer-specific survival in head and neck cancer: findings from a large, population-based study.

Authors:  Linda Sharp; Joseph McDevitt; Anne-Elie Carsin; Christopher Brown; Harry Comber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-15       Impact factor: 4.254

4.  Oral squamous cell carcinoma: a clinicopathological study on 194 cases in northeastern Brazil. A cross-sectional retrospective study.

Authors:  Amanda Almeida Leite; Augusto César Leal da Silva Leonel; Jurema Freire Lisboa de Castro; Elaine Judite de Amorim Carvalho; Pablo Agustin Vargas; Luiz Paulo Kowalski; Danyel Elias da Cruz Perez
Journal:  Sao Paulo Med J       Date:  2018-03-22       Impact factor: 1.044

5.  Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk.

Authors:  Manuela Marron; Paolo Boffetta; Zuo-Feng Zhang; David Zaridze; Victor Wünsch-Filho; Deborah M Winn; Qingyi Wei; Renato Talamini; Neonila Szeszenia-Dabrowska; Erich M Sturgis; Elaine Smith; Stephen M Schwartz; Peter Rudnai; Mark P Purdue; Andrew F Olshan; Jose Eluf-Neto; Joshua Muscat; Hal Morgenstern; Ana Menezes; Michael McClean; Elena Matos; Ioan Nicolae Mates; Jolanta Lissowska; Fabio Levi; Philip Lazarus; Carlo La Vecchia; Sergio Koifman; Karl Kelsey; Rolando Herrero; Richard B Hayes; Silvia Franceschi; Leticia Fernandez; Eleonora Fabianova; Alexander W Daudt; Luigino Dal Maso; Maria Paula Curado; Gabriella Cadoni; Chu Chen; Xavier Castellsague; Stefania Boccia; Simone Benhamou; Gilles Ferro; Julien Berthiller; Paul Brennan; Henrik Møller; Mia Hashibe
Journal:  Int J Epidemiol       Date:  2009-10-05       Impact factor: 7.196

6.  Prevalence of tobacco use and perceptions of student health professionals about cessation training: results from Global Health Professions Students Survey.

Authors:  Chandrashekhar T Sreeramareddy; N Ramakrishnareddy; Mahbubur Rahman; Imtiyaz Ali Mir
Journal:  BMJ Open       Date:  2018-05-26       Impact factor: 2.692

7.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.

Authors:  Stephen M Kissler; Christine Tedijanto; Yonatan H Grad; Marc Lipsitch; Edward Goldstein
Journal:  Science       Date:  2020-04-14       Impact factor: 47.728

8.  COVID-19 and Smoking.

Authors:  Ivan Berlin; Daniel Thomas; Anne-Laurence Le Faou; Jacques Cornuz
Journal:  Nicotine Tob Res       Date:  2020-08-24       Impact factor: 4.244

  8 in total
  3 in total

1.  The double-edged relationship between COVID-19 stress and smoking: Implications for smoking cessation.

Authors:  Jeroen Bommele; Petra Hopman; Bethany Hipple Walters; Cloé Geboers; Esther Croes; Geoffrey T Fong; Anne C K Quah; Marc Willemsen
Journal:  Tob Induc Dis       Date:  2020-07-27       Impact factor: 2.600

2.  Impact of the COVID-19 pandemic on smoking behavior and beliefs among the American University of Beirut community.

Authors:  Yasmina Al Ghadban; Nathalie Zgheib; Maya Romani; Imad Bou Akl; Rihab Nasr
Journal:  Tob Prev Cessat       Date:  2022-01-24

3.  Brazilian oral medicine and oral pathology: We are here during the COVID-19 pandemic.

Authors:  Hercílio Martelli Júnior; Renato Assis Machado; Paulo Rogério Ferreti Bonan; Danyel Elias da Cruz Perez; Fábio Ramôa Pires; Fábio Abreu Alves
Journal:  Oral Dis       Date:  2020-06-18       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.